Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
02/2014
02/19/2014EP2696873A2 Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
02/19/2014EP2696863A1 Use of calixarenes associated with an antibiotic in the treatment of bacterial infections
02/19/2014EP2696862A1 Use of calixarenes in the treatment of bacterial infections
02/19/2014EP2696849A1 Compositions and methods for inhibiting and/or modulating effector t-cells involved in inflammatory neurodegenerative disease
02/19/2014EP2696681A1 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
02/19/2014CN103596561A Compositions containing resveratrol and essential oil of cloves for the treatment of itching
02/19/2014CN103596455A Food composition for intra-operative tube feeding
02/19/2014CN103585632A Application of bile acid chelating agent or/and vitamin D in preparing drug for preventing and treating non-alcoholic fatty liver disease
02/19/2014CN103585631A Method for preventing and treating tumors by using microRNA sponge technology
02/19/2014CN103585630A Applications of I-type histone deacetylase (HDAC) inhibitor in inhibition of renal fibrosis
02/19/2014CN103585629A New target for preventing and treating insulin resistance and its related diseases
02/19/2014CN103585243A Application of Solms-Laubachia extract in preparation of anticancer drugs
02/19/2014CN103585223A Application of Picris japonica extract in preparation of drugs treating AIDS
02/19/2014CN103585209A Application of Dorema ammoniacum resin extract in preparation of anti-liver cancer drugs
02/19/2014CN103585135A Application of magnolol to preparation of medicine for treating cachexia and cancer
02/19/2014CN103585103A Sex hormone micro-nano human body injection emulsion containing TPGS, and preparation method thereof
02/19/2014CN102847157B Traditional Chinese medicine composition for treating nephropathy through targeted transferring in renal region
02/18/2014US8653120 Method for treatment of chronic neuropathic pain
02/18/2014US8653117 Composition comprising at least one oxazoline to inhibit migration of langerhans cells, and uses thereof
02/18/2014US8653033 Method for administering omega-conopeptide
02/18/2014US8653030 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
02/18/2014US8653026 Treatment of type 2 diabetes with FTY720
02/18/2014US8652481 Mycoplasma bovis vaccine and methods of use thereof
02/18/2014US8652464 Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer
02/18/2014US8652462 Immune regulation
02/18/2014US8652439 Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis
02/18/2014CA2743255C Infarct area perfusion-improving compositions and methods of vascular injury repair
02/18/2014CA2624492C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
02/18/2014CA2567495C Methods for treating bleeding disorders using sulfated polysaccharides
02/18/2014CA2560472C Method for improved breast milk feeding to reduce the risk of allergy
02/18/2014CA2500742C Compositions of fgf-18 and hyaluronic acid for stimulating cartilage production and treating osteoarthritis
02/18/2014CA2429814C Rna interference mediating small rna molecules
02/13/2014WO2014024820A1 Pharmaceutical composition for treating new chronic kidney disease and method for screening medicine for new chronic kidney disease
02/13/2014WO2014024168A1 Polymeric crown ether derivatives used in the treatment of proliferative diseases, in particular cancer
02/13/2014WO2014023732A1 Niclosamide and its derivatives for use in the treatment of solid tumors
02/13/2014WO2014023329A1 Niclosamide and its derivatives for use in the treatment of solid tumors
02/13/2014WO2014023288A1 Method for introducing biologically active substances into the brain
02/13/2014US20140047572 Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury
02/13/2014US20140046287 Microfabricated nanopore device for sustained release of therapeutic agent
02/13/2014US20140046255 Free-standing biodegradable patch
02/13/2014US20140045932 Flavanol and carotenoid compositions
02/13/2014US20140045930 Assay for arginyl hydroxylase activity
02/13/2014US20140045909 Denibulin di-hydrochloride
02/13/2014US20140045907 Use of Inhibitors of the Renin-Angiotensin System
02/13/2014US20140045906 Neprilysin inhibitors
02/13/2014US20140045900 Administration regime for nitrocatechols
02/13/2014US20140045898 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
02/13/2014US20140045896 1,4-dihydropyridine-3,5-dicarboxylate Derivatives And Preparation And Use Thereof
02/13/2014US20140045872 17a-HYDROXYLASE/C17,20-LYASE INHIBITORS
02/13/2014US20140045847 Crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
02/13/2014US20140045843 Methods of treating cancer using 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
02/13/2014US20140045838 Kinase inhibitors and method of treating cancer
02/13/2014US20140045831 Bicyclic heterocycle compounds and their uses in therapy
02/13/2014US20140045823 N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof
02/13/2014US20140045822 Kinase inhibitors and method of treating cancer with same
02/13/2014US20140045818 Benzothiazole compounds and their pharmaceutical use
02/13/2014US20140045802 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
02/13/2014US20140045800 Tetracyclic inhibitors of fatty acid amide hydrolase
02/13/2014US20140045796 Transient hypoxia inducers and their use
02/13/2014US20140045795 Compounds for the treatment of proliferative disorders
02/13/2014US20140045790 Novel Bicyclic Pyridinones
02/13/2014US20140045783 Nucleoside phosphoramidate prodrugs
02/13/2014US20140045780 Compositions comprising spicamycin derivatives and methods of use thereof
02/13/2014US20140045779 Compounds containing an alicyclie structure and anti-tumor application
02/13/2014US20140045756 Methods and compositions for modulating tnf/tnfr signaling
02/13/2014US20140045755 Methods for treating sleep disorders by cholecystokinin (cck) receptor b antagonists
02/13/2014US20140045750 Methods of protecting against apoptosis using lipopeptides
02/13/2014US20140045746 Antidiabetic tricyclic compounds
02/13/2014US20140045745 Diketopiperazine microparticles with defined specific surface areas
02/13/2014US20140044806 New positive allosteric modulators of nicotinic acetylcholine receptor
02/13/2014US20140044803 Method of using flibanserin for neuroprotection
02/13/2014US20140044802 Compounds useful as inhibitors of atr kinase and combination therapies thereof
02/13/2014US20140044797 Prostacyclin and analogs thereof administered during surgery for prevention and treatment of capillary leakage
02/13/2014US20140044786 Once-weekly oral administration of aripiprazole
02/13/2014US20140044782 Controlled release formulations of opioid and nonopioid analgesics
02/13/2014US20140044771 Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereof
02/13/2014US20140044747 Combination vaccine
02/13/2014US20140044729 Antibody and antigen recognizing tumor-initiating cells and use thereof
02/13/2014US20140044722 Anti-sod1 antibodies and uses thereof
02/13/2014US20140044713 Compounds
02/13/2014US20140044706 Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
02/13/2014US20140044705 Combination therapy of an afucosylated cd20 antibody with bendamustine
02/13/2014US20140044704 Treatment of metastatic breast cancer
02/13/2014US20140044702 Diagnosis and treatments relating to th2 inhibition
02/13/2014US20140044692 Impaired energy processing disorders and mitochondrial deficiency
02/13/2014US20140044689 Methods and compositions for preventing or treating ophthalmic conditions
02/13/2014US20140044685 Nutritional compositions having alpha-hica and citrulline
02/13/2014US20140042051 Pharmaceutical foam
02/12/2014EP2696203A2 Tumor cell-derived microvesicles
02/12/2014EP2695621A1 Pharmaceutical preparation
02/12/2014EP2695617A2 Vitamin D glycosides and sulfates for treating intestinal diseases
02/12/2014EP2694078A1 Selection of hcv treatment
02/12/2014EP2694074A1 Use of a2b adenosine receptor antagonists for treating heart failure and arrhythmia in post-myocardial infarction patients
02/12/2014EP2694073A1 Combinations of akt and mek inhibitor compounds, and methods of use
02/12/2014EP2694065A2 Treatment regimens
02/12/2014EP2694052A1 Sn-1(3) monoacylglycerides and lipid absorption
02/12/2014EP2694048A2 Ophthalmic treatments
02/12/2014EP2694046A1 Methods and pharmaceutical compositions for inhibiting influenza viruses replication
02/12/2014EP2694045A1 New combination comprising n-acetyl-l-cysteine and its use
02/12/2014EP2693898A1 Food composition for intra-operative tube feeding
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 1151